CDRH stakeholders meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA Associate Commissioner for Strategic Management Linda Suydam and CDRH Director Bruce Burlington are members of an agency panel that will convene at an Aug. 18 public meeting on Sec. 406(b) of the FDA Modernization Act. The meeting, which is mandated under FDAMA, will be divided into three sections, including: Medical Device Users (Part One) and Health Organizations; Trade Associations/Standards Organizations; and Medical Device Users (Part Two) and Patients and Consumers. The meeting begins at 9:00 a.m. in the HHS Humphrey Building in Washington, D.C. FDA will hold a second public meeting on the issue on Sept. 14. For further information, contact Catherine Beck at 301/827-3443